Enter your login e-mail to the account
Search
Search parameters
Search results
- The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(11/2009, Review articles ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - How early diagnose urological malignancy in the office of a general practitioner
doc. MUDr. Jozef Marenčák, PhD.
(5/2014, Review articles )
- Immunotherapy in the treatment of urological malignancies
MUDr. Jana Katolická, Ph.D., MUDr. Petr Filipenský, Ph.D.
(3/2019, Review articles ) - ACTUAL MEDICATION OF THE BONE METASTASE
MUDr. Ivan Kolombo, FEBU, MUDr. Martina Poršová, MUDr. Jaroslav Porš, MUDr. Richard Pabišta
(5-6/2007, Review articles ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology ) - Extensive retroperitoneal lymphadenopathy with accompanying renal pain as a manifestation of rare „burned-out” germ cell testicular tumor
MUDr. Maksym Falion, MUDr. Jiří Král, MUDr. Miloš Bočan, MUDr. Zdeněk Peremský
(5/2016, Communication from practice )
- Systemic therapy of bone metastases
MUDr. Andrea Škripeková
(4/2012, Main topic ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - Nephroblastoma – diagnostics problems and treatment
MUDr. Kristína Husáková
(1/2009, Review articles ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Current recommendations for bisphosphonates therapy in cancer patients
prof. MUDr. Stanislav Špánik, CSc., MUDr. Beata Špániková, PhD.
(6/2013, Review articles ) - Publikujeme v zahraničí
(6/2013, Information & comments ) - Management of adverse reactions in treatment with mTOR and CDK4/6 inhibitors
MUDr. Branislav Bystrický, PhD., MPH
(2/2019, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - The current view of the familial adenomatous polyposis (FAP)
MUDr. Vladimír Holec, doc. RNDr. Vladimír Zajac, CSc., Mgr. Zuzana Adamčíková, Ing. Mgr. Katarína Hainová, RNDr. Soňa Čierniková, PhD., Viola Števurková
(2/2012, Review articles ) - Publikujeme v zahraničí
(2/2012, Information & comments ) - Ipilimumab in the treatment of malignant melanoma
MUDr. Róbert Godál
(3/2011, Drugs & drug classes ) - New recommendations for adjuvant and first-line treatment of metastatic clear cell renal carcinoma
MUDr. Milan Krošlák
(4/2022, Main topic ) - Late toxicity in patients with testicular germ cell tumors
MUDr. Michaela Sojáková, MUDr. Katarína Rejleková, PhD.
(3/2016, Main topic ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Treatment of patients with metastatic renal cancer after treatment with tyrosine kinase inhibitors
MUDr. Mária Rečková, PhD.
(4/2019, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - Role of pathologist in the diagnosis of cancer of unknown primary origin
doc. MUDr. Karol Kajo, PhD.
(4/2013, Main topic ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Optimal first line treatment in advanced/metastatic renal carcinoma-immunotherapy, targeted therapy, combinations
MUDr. Katarína Rejleková, PhD.
(6/2020, Review articles ) - Publikujeme v zahraničí
(1/2015, Information & comments ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Odporúčania Slovenskej onkologickej spoločnosti SLS pre použitie bisfosfonátov v liečbe solídnych nádorov
prof. MUDr. Stanislav Špánik, CSc.
(4/2009, Recommendations ) - Publikujeme v zahraničí
(4/2015, Information & comments ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - Surgical treatment of pancreas carcinoma
prof. MUDr. Juraj Pechan, CSc., MUDr. Róbert Duchoň, doc. MUDr. Daniel Pinďák, PhD., MUDr. Róbert Šucha, MUDr. Jozef Dolník
(3/2012, Main topic ) - Rare lung cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Main topic ) - Immune therapy of metastatic renal cell carcinoma
MUDr. Michal Chovanec, PhD.
(4/2016, Main topic ) - Surgical treatment of spinal metastases
MUDr. Peter Tisovský, PhD., MUDr. Juraj Horváth, PhD., MUDr. Karol Novorolský, MUDr. Andrey Švec, PhD.
(4/2016, Review articles ) - Publikujeme v zahraničí
(2/2013, Information & comments ) - Metabolic complications in oncology
MUDr. Zuzana Syčová-Milá
(1/2012, Review articles ) - ABC transporters: multidrug resistance and different types of human diseases
prof. MUDr. Stanislav Špánik, CSc., doc. MUDr. Viera Lehotská, PhD., MUDr. Katarína Rauová, RNDr. Eva Weismanová, PhD., RNDr. Ľubomír Horváth, CSc., Mgr. Ján Markus, PhD., MUDr. Ladislav Sopko
(1/2012, Review articles ) - Current trends in surgery of Wilms tumor
MUDr. Terézia Stančoková, MUDr. Pavel Bician, MUDr. Vladimír Baláž, PhD., MUDr. Ján Novotný, MUDr. Jozef Babeľa, MUDr. Július Janek, PhD., MUDr. Roman Koreň, PhD.
(1/2016, Main topic ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(6/2012, Information & comments ) - The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(5/2009, Review articles ) - Initial treatment of metastatic renal cell carcinoma
MUDr. Jana Obertová, PhD.
(1/2018, Main topic ) - Diagnosis of melanoma
prof. MUDr. Lukáš Plank, CSc., MUDr. Martina Bobrovská, MUDr. Eva Minariková, PhD.
(3/2009, Review articles ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic )
- Stem cells in surgery
MUDr. Martina Fialová, MUDr. Ivan Brychta, PhD.
(2/2012, Review articles )